CTI BioPharma Corp. Profile Avatar - Palmy Investing

CTI BioPharma Corp.

CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhi…

Biotechnology
US, Seattle [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

CTI BioPharma Corp. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

CTI BioPharma Corp. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of CTI BioPharma Corp..

End of CTIC's Analysis
CIK: 891293 CUSIP: 12648L601 ISIN: US12648L6011 LEI: - UEI: -
Secondary Listings
CTIC has no secondary listings inside our databases.